US 9303044
7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders
granted A61KA61K31/337A61K31/4353
Quick answer
US patent 9303044 (7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/337, A61K31/4353, A61K31/436, A61K31/519